France Diabetes Device Market Forecast Report by Types, Distribution Channel, Cities and Company Analysis 2026-2034

France Diabetes Devices Market Size and Forecast 2026-2034

The France Diabetes Device Market is projected to grow from USD 1,081.90 Million in 2025 to USD 2,048.60 Million in 2034. It is estimated to grow at a CAGR of 7.36% from 2026 to 2034. The growth in the market is driven by the increasing number of people with diabetes, government healthcare support, the use of glucose tracking solutions, and the government's favorable reimbursement support. Continuous innovation and the growing need to monitor diabetes at home are factors that aid in market development.

France Diabetes Devices Market Outlook

Diabetes care devices are designed to help a person measure, control, and manage blood sugar levels effectively in a manner that helps in effectively dealing with diabetes. The devices that come under the diabetes care devices range from blood glucometers, CGM, insulin pens, and insulin pumps. The devices help a certain individual accurately test his/her sugar levels, calculate the dosage of insulin, and monitor his/her sugar levels in a manner that prevents diabetes-related complications like heart disease, nerve disorders, and renal disorder. With advancements in technology, the diabetes care devices now support various digital applications.

In France, diabetes care devices have gained immense popularity due to the strong public healthcare infrastructure and prevailing awareness levels about the importance of chronic disease management. Reimbursement schemes also contribute favorably towards making glucose testing and insulin delivery devices easily accessible to larger communities. Diabetes care devices have been widely encouraged by healthcare practitioners in France, especially by those requiring insulin, as part of advanced technology introduction, especially concerning concentrated glucose monitors. The increased number of senior citizens and home-based care have also driven the use of diabetes care devices.

Factors Driving the Growth of the France Diabetes Devices Market

Robust Public Healthcare Infrastructure & Favorable Reimbursement Terms

One of the most key drivers in the growth of the diabetes devices market in France is the attractiveness of its public health infrastructure. There is extensive coverage in France for the treatment of diabetes in terms of glucose monitoring systems, test strips, insulin pens, and increasingly, Continuous Glucose Monitors as well. This leads to lower out-of-pocket costs for the patient and pushes the need to detect and monitor the disease regularly. When there are chances of reimbursement, physicians are more likely to prescribe the most advanced technologies available in the field of diabetes, and this pushes the growth of the market at a rapid rate. There is a proper channel formed in France in the field of health infrastructure to manage chronic diseases, which leads to the long-term demand in the French market for the import and usage of diabetes-related devices. Aug 2025, The French National Authority for Health (HAS) publishes guidelines on the listing of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following an assessment by the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS).

Increasing Prevalence of Diabetes and Aging Population

Rising cases of diabetes, especially type 2, coupled with the aging population in France, are driving the market. Older people are more vulnerable to chronic diseases, including the need for frequent glucose tests and insulin administration. Lifestyle factors, lack of exercise, and food habits have also led to the increased number of people suffering from diabetes. Since diabetics need lifelong treatment, the rising number of people suffering from the condition is expected to fuel the market for SMBG, CGM, and insulin delivery systems. Approximately 3.5 million people in France are suffering from diabetes, an increase from the 2024 figure, and the prevalence rate for men already stands between 3% to 5%.

Adoption of Advanced & Digital Technologies in Diabetes

The adoption of advanced technology in the treatment and management of diabetes is increasing rapidly in the country of France. These technologies include CGM technology, smart insulin pens, and other monitoring gadgets. This technology can be used with various apps and data exchange systems. This technology is being widely accepted by the health and medical sector to ensure better treatment and patient cooperation. This technology is increasing the demand for innovative devices to be used in the management and treatment of diabetes. In September 2023, According to Dexcom, people with diabetes are now able to access the Dexcom ONE system, which is a real-time continuous glucose monitor. This is great news for the diabetic patient community. This life-saving technology will be available to an extra 500,000 diabetic patients in the country of France.

Obstacles in the France Diabetes Devices Market

Handling of the Issue by the Chinese Government

The French diabetes devices industry has been affected by factors like strict regulatory policies and long approval times. The devices have to meet EU as well as domestic regulations, thereby hindering companies from launching their devices in the market, thus adding to development costs. Small companies may not be able to meet the requirements, thus hindering innovation and competition.

Pressure and Budget Concerns in Healthcare Industries

Although the reimbursement rates are very favorable, cost containment is a challenge. The healthcare authorities of the country continually evaluate the cost-effectiveness of products. This creates pressure on device companies regarding pricing. Resource constraints might delay the adoption of new and expensive technologies. This is a major challenge for the diabetes devices marketplace in the country.

France SMBG Devices Market

France's self-monitoring of blood glucose (SMBG) devices market has been the foundation of diabetes management. SMBG devices like glucose meters, strips, and lancets have been prescribed for the regular monitoring of blood glucose levels among type 1 as well as type 2 diabetes patients. Ease of use, accuracy, and applicability at the home healthcare level of the patient have been the key factors favoring a high adoption rate. French healthcare professionals regard regular self-monitoring of blood glucose as a key part of the comprehensive management of the diabetes patient. Advances in accuracy and connectivity of the device have made this requirement easier for the patient. Ease of access at pharmacies and hospitals has made SMBG devices the utmost preferred choice even as new technologies gain popularity.

France CGM Devices Market

The continuous glucose monitoring system market in France is growing at a brisk pace because of the favorable reimbursements and awareness and acceptance of the technology. The technology offers real-time glucose values and trend information, which helps in effective glucose control and the prevention of hypoglycemia. The technology is predominantly used by people with Type 1 diabetes and insulin-requiring people with Type 2 diabetes. The use of the technology with mobile applications and sharing services facilitates home monitoring and management. As people become aware of the long-term benefits of the technology, it is now being prescribed by endocrinologists, and this category is one of the fastest-growing in the market in France.

French Insulin Pump Devices Market

The market for insulin pump devices in France is steadily growing as patients increasingly demand better technology for their insulin delivery systems. The benefits associated with using insulin pumps include continuous and accurate insulin dosages, leading to better blood glucose control and life quality. Being closely monitored and requiring training might act as an impeding factor when using the devices, but this issue has been addressed by the availability of advanced facilities at diabetes centers and hospitals for patient assistance.

France Insulin Pen Devices Market

The insulin pen device is very common in France because it is convenient to use. The insulin pen is often prescribed in France for people with type 2 diabetes who now need insulin. The insulin pen is either disposable or reusable. The insulin pen is well supported by reimbursement. The patients would like the insulin injection to be discreet and convenient. The development in pen technology helps ensure growth. November 2023: Novo Nordisk expanded their plant in France in response to growing insulin device sales in Europe.

France Diabetes Devices Hospital Pharmacies Market

Hospital pharmacies are essential in the distribution of diabetes products in the French market, especially for people who are insulin-dependent. The recommendation of the physician has played an integral role in the selection of these products, hence the high level of trust in those distributed by hospitals. Their role in training patients on these products, especially CGM systems and insulin pumps, should also not go unmentioned.

France Diabetes Devices Online Pharmacies Market

Online pharmacies are becoming more popular in the French market as an excellent means of accessing diabetes care devices and consumables. This is due to the benefits associated with online pharmacies, such as the ability to receive deliveries at home and the low cost of the devices and consumables. Online pharmacies are gradually increasing their share of the market.

Paris Diabetes Devices Market

The diabetes device market in the Paris region has the most advanced level of development in the country, thanks to high spending on health, awareness, and exposure to world-class facilities within the region's hospitals and medical centers. Top-class public hospitals, as well as exclusive health facilities, exist within Paris, focusing on endocrinology as a critical area of expertise among medical professionals here. The regional population has a marked predisposition to adopting cutting-edge technology for maintaining their diabetic health, namely continuous glucose monitoring systems, insulin pumps, as well as smart insulin pens. The support of reimbursements and endorsement by specialist physicians further fuels their adoption. The region's infrastructure for health technology, enabling monitoring as well as Bluetooth connectivity to mobile apps, supporting diabetes care, further propitiates sustained demand for basic as well as advanced diabetes care devices, turning Paris into a prime mover for the entire nation's growth within the diabetes device market.

Marseille Diabetes Devices Market

The Marseille market for diabetic devices is expanding steadily with the support of improving health care and growing awareness about the management of diabetic patients. Being one of the biggest cities in southern France, Marseille represents a vastly different patient base, with an increasing preponderance of type 2 diabetic patients due to lifestyle and demographic reasons. SMBG devices and insulin pens have been very common, especially in public and retail pharmaceutical stores. However, there has been a steady rise in the use of CGM devices, especially with improving awareness and specialist health care support being tapped by increasing numbers of people. Public health care institutions have been playing an important role in patient awareness and providing access to devices, and specialist clinics are starting to promote the use of advanced devices.

Nantes Diabetes Devices Market

The Nantes diabetes devices market is distinguished by sustained growth and an increasing trend of adopting contemporary methods of diabetes management. The Nantes region is well-supported by an organized healthcare structure, which promotes early diagnosis and chronic monitoring of diabetes. SMBG devices and insulin pens continue to be the oldest and most widely used methods, due to favorable reimbursement patterns and recommendations by healthcare professionals. The trend of adopting CGM devices continues gaining momentum, especially in people requiring insulin intake on a continued basis, requiring constant monitoring of glucose levels. The Nantes trend of promoting prevention and home care will hopefully lead to balanced growth in adoption of contemporary devices in this city as well.

Market Segmentation

Types

• Self-Monitoring Devices
• Continuous Glucose-Monitoring Devices
• Insulin Pumps
• Insulin Pens

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies

Top City

• Paris
• Lyon
• Marseille
• Toulouse
• Bordeaux
• Lille
• Nantes
• Strasbourg
• Nice
• Montpellier
• Rest of Cities

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis

• BD
• Medtronic
• Tandem Diabetes Care
• Novo Nordisk A/S
• Roche
• Abbott Laboratories
• Eli Lilly
• Ypsomed AG
• Dexcom Inc